CUSTOM TECHNOLOGY ACCESS AND PRODUCT LICENSE AGREEMENTStock Transfer Agreement • November 22nd, 2010 • Cardium Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
This Custom Technology Access and Product License Agreement (the “Agreement”) is made and entered into as of the 17th of November, 2010 (the “Effective Date”), by and between Cardium Therapeutics, Inc., a Delaware corporation with offices at 12255 El Camino Real, Suite 250, San Diego, CA 92130, on behalf of itself and its affiliates (“Cardium”) and BioZone Laboratories, Inc., a California C corporation, with offices at 580 Garcia Ave., Pittsburg, CA 94565, and its affiliate EquaChem LLC, a California limited liability company, with offices at 580 Garcia Ave., Pittsburg, CA 94565 (individually and collectively “BioZone”). Cardium and BioZone are each referred to as a party and collectively parties to this Agreement.
